Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × Androgen Antagonists × Clear all

NCT06312670 2025-05-29

Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer

Phase 2 Completed

Neoplasm Metastasis, Prostatic Neoplasms

NCT03569241 2024-12-09

STORM

Phase 2 Active not recruiting

Neoplasm Metastasis, Prostatic Neoplasms